Cornelia Mundt

502 total citations
12 papers, 378 citations indexed

About

Cornelia Mundt is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Cornelia Mundt has authored 12 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Cornelia Mundt's work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (3 papers). Cornelia Mundt is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (3 papers). Cornelia Mundt collaborates with scholars based in United Kingdom, Germany and United States. Cornelia Mundt's co-authors include Inga‐Lill Mårtensson, Steve Licence, Fritz Melchers, Takeyuki Shimizu, Thomas Winkler, Antonius Rolink, Roberta Pelanda, Gunther R. Galler, Arnd Petersen and Max Schlaak and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Cornelia Mundt

11 papers receiving 374 citations

Peers

Cornelia Mundt
U Grawunder Switzerland
Carina Olsson Switzerland
Siska Wijngaarden Netherlands
H.P. Tony Germany
E Nößner Germany
Julia Halper United States
U Grawunder Switzerland
Cornelia Mundt
Citations per year, relative to Cornelia Mundt Cornelia Mundt (= 1×) peers U Grawunder

Countries citing papers authored by Cornelia Mundt

Since Specialization
Citations

This map shows the geographic impact of Cornelia Mundt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Mundt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Mundt more than expected).

Fields of papers citing papers by Cornelia Mundt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelia Mundt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Mundt. The network helps show where Cornelia Mundt may publish in the future.

Co-authorship network of co-authors of Cornelia Mundt

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelia Mundt. A scholar is included among the top collaborators of Cornelia Mundt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelia Mundt. Cornelia Mundt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Galand, C, Yanping Xiao, Cornelia Mundt, et al.. (2019). AGEN2373 is a conditionally-active agonist antibody targeting the costimulatory receptor CD137 for the treatment of human malignancies.. Journal of Clinical Oncology. 37(15_suppl). e14005–e14005.
2.
Savitsky, David A., Rebecca Ward, Cornelia Mundt, et al.. (2018). Abstract 3819: INCAGN02385 is an antagonist antibody targeting the co-inhibitory receptor LAG-3 for the treatment of human malignancies. Cancer Research. 78(13_Supplement). 3819–3819. 22 indexed citations
3.
Mundt, Cornelia, Steve Licence, Gavin Maxwell, Fritz Melchers, & Inga‐Lill Mårtensson. (2005). Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells. International Immunology. 18(1). 163–172. 13 indexed citations
4.
Galler, Gunther R., et al.. (2004). Surface μ Heavy Chain Signals Down-Regulation of the V(D)J-Recombinase Machinery in the Absence of Surrogate Light Chain Components. The Journal of Experimental Medicine. 199(11). 1523–1532. 49 indexed citations
5.
Licence, Steve, et al.. (2003). The VpreB1 enhancer drives developmental stage‐specific gene expression in vivo. European Journal of Immunology. 33(4). 1117–1126. 2 indexed citations
6.
Shimizu, Takeyuki, Cornelia Mundt, Steve Licence, Fritz Melchers, & Inga‐Lill Mårtensson. (2002). VpreB1/VpreB2/λ5 Triple-Deficient Mice Show Impaired B Cell Development but Functional Allelic Exclusion of the IgH Locus. The Journal of Immunology. 168(12). 6286–6293. 107 indexed citations
7.
Mårtensson, Inga‐Lill, Antonius Rolink, Fritz Melchers, et al.. (2002). The pre-B cell receptor and its role in proliferation and Ig heavy chain allelic exclusion. Seminars in Immunology. 14(5). 335–342. 50 indexed citations
8.
Mundt, Cornelia, I. Nicholson, Xiangang Zou, et al.. (2001). Novel Control Motif Cluster in the IgH δ-γ3 Interval Exhibits B Cell-Specific Enhancer Function in Early Development. The Journal of Immunology. 166(5). 3315–3323. 16 indexed citations
9.
Petersen, Arnd & Cornelia Mundt. (2001). Investigations on the carbohydrate moieties of glycoprotein allergens. Journal of Chromatography B Biomedical Sciences and Applications. 756(1-2). 141–150. 14 indexed citations
10.
Mundt, Cornelia, Steve Licence, Takeyuki Shimizu, Fritz Melchers, & Inga‐Lill Mårtensson. (2001). Loss of Precursor B Cell Expansion but Not Allelic Exclusion in VpreB1/VpreB2 Double-Deficient Mice. The Journal of Experimental Medicine. 193(4). 435–446. 86 indexed citations
11.
Mundt, Cornelia, et al.. (2000). Alpha-glucosylrutin An antioxidative modulator of the UVA-induced ERK1/2 MAP kinase activation in normal and atopic skin. Journal of Investigative Dermatology. 114(4). 842. 3 indexed citations
12.
Mundt, Cornelia, et al.. (1996). Farmer's lung: Patients’ IgG2 antibodies specifically recognize Saccharopolyspora rectivirgula proteins and carbohydrate structures. Journal of Allergy and Clinical Immunology. 98(2). 441–450. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026